Ortonne, J., Shear, N., Shumack, S., & Henninger, E. (2005). Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: Results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]. BioMed Central.
Citação norma ChicagoOrtonne, Jean-Paul, Neil Shear, Stephen Shumack, and Eric Henninger. Impact of Efalizumab On Patient-reported Outcomes in High-need Psoriasis Patients: Results of the International, Randomized, Placebo-controlled Phase III Clinical Experience Acquired With Raptiva (CLEAR) Trial [NCT00256139]. BioMed Central, 2005.
Citação norma MLAOrtonne, Jean-Paul, Neil Shear, Stephen Shumack, and Eric Henninger. Impact of Efalizumab On Patient-reported Outcomes in High-need Psoriasis Patients: Results of the International, Randomized, Placebo-controlled Phase III Clinical Experience Acquired With Raptiva (CLEAR) Trial [NCT00256139]. BioMed Central, 2005.